88 related articles for article (PubMed ID: 21381906)
21. Urodynamics after TURP and HoLEP in urodynamically obstructed patients: are there any differences at 1 year of follow-up?
Rigatti L; Naspro R; Salonia A; Centemero A; Ghezzi M; Guazzoni G; Briganti A; Rigatti P; Montorsi F
Urology; 2006 Jun; 67(6):1193-8. PubMed ID: 16750253
[TBL] [Abstract][Full Text] [Related]
22. Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome.
Bachmann A; Schürch L; Ruszat R; Wyler SF; Seifert HH; Müller A; Lehmann K; Sulser T
Eur Urol; 2005 Dec; 48(6):965-71; discussion 972. PubMed ID: 16126327
[TBL] [Abstract][Full Text] [Related]
23. High power diode laser vaporization of the prostate: preliminary results for benign prostatic hyperplasia.
Erol A; Cam K; Tekin A; Memik O; Coban S; Ozer Y
J Urol; 2009 Sep; 182(3):1078-82. PubMed ID: 19616811
[TBL] [Abstract][Full Text] [Related]
24. High-performance system GreenLight laser: indications and outcomes.
Van Cleynenbreugel B; Srirangam SJ; Van Poppel H
Curr Opin Urol; 2009 Jan; 19(1):33-7. PubMed ID: 19057213
[TBL] [Abstract][Full Text] [Related]
25. Holmium laser enucleation of the prostate--outcomes independent of prostate size?
Humphreys MR; Miller NL; Handa SE; Terry C; Munch LC; Lingeman JE
J Urol; 2008 Dec; 180(6):2431-5; discussion 2435. PubMed ID: 18930490
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of greenlight photoselective vaporization of the prostate for the treatment of high-risk patients with benign prostatic hyperplasia.
Fu WJ; Hong BF; Wang XX; Yang Y; Cai W; Gao JP; Chen YF; Zhang CE
Asian J Androl; 2006 May; 8(3):367-71. PubMed ID: 16625289
[TBL] [Abstract][Full Text] [Related]
27. Urodynamic effects of once daily tadalafil in men with lower urinary tract symptoms secondary to clinical benign prostatic hyperplasia: a randomized, placebo controlled 12-week clinical trial.
Dmochowski R; Roehrborn C; Klise S; Xu L; Kaminetsky J; Kraus S
J Urol; 2010 Mar; 183(3):1092-7. PubMed ID: 20092847
[TBL] [Abstract][Full Text] [Related]
28. Prostatic stents for the treatment of benign prostatic hyperplasia.
Vanderbrink BA; Rastinehad AR; Badlani GH
Curr Opin Urol; 2007 Jan; 17(1):1-6. PubMed ID: 17143103
[TBL] [Abstract][Full Text] [Related]
29. Transurethral resection of the prostate: failure patterns and surgical outcomes in patients with symptoms refractory to alpha-antagonists.
Blanchard K; Hananel A; Rutchik S; Sullivan J
South Med J; 2000 Dec; 93(12):1192-6. PubMed ID: 11142455
[TBL] [Abstract][Full Text] [Related]
30. [Transurethral holmium laser enucleation of the prostate for the treatment of benign prostatic hyperplasia].
Wu Z; Ding Q; Jiang HW; Chen ZX; Zhang HW; Li CJ; Zhang YF
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(36):2560-2. PubMed ID: 17198566
[TBL] [Abstract][Full Text] [Related]
31. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
[TBL] [Abstract][Full Text] [Related]
32. A randomized trial of photoselective vaporization of the prostate using the 80-W potassium-titanyl-phosphate laser vs transurethral prostatectomy, with a 1-year follow-up.
Bouchier-Hayes DM; Van Appledorn S; Bugeja P; Crowe H; Challacombe B; Costello AJ
BJU Int; 2010 Apr; 105(7):964-9. PubMed ID: 19912196
[TBL] [Abstract][Full Text] [Related]
33. High power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate in 66 high risk patients.
Reich O; Bachmann A; Siebels M; Hofstetter A; Stief CG; Sulser T
J Urol; 2005 Jan; 173(1):158-60. PubMed ID: 15592063
[TBL] [Abstract][Full Text] [Related]
34. Modifiable risk factors for benign prostatic hyperplasia and lower urinary tract symptoms: new approaches to old problems.
Parsons JK
J Urol; 2007 Aug; 178(2):395-401. PubMed ID: 17561143
[TBL] [Abstract][Full Text] [Related]
35. High power potassium-titanyl-phosphate laser vaporization prostatectomy.
Malek RS; Kuntzman RS; Barrett DM
J Urol; 2000 Jun; 163(6):1730-3. PubMed ID: 10799170
[TBL] [Abstract][Full Text] [Related]
36. The effects of dutasteride, tamsulosin and combination therapy on lower urinary tract symptoms in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results from the CombAT study.
Roehrborn CG; Siami P; Barkin J; Damião R; Major-Walker K; Morrill B; Montorsi F;
J Urol; 2008 Feb; 179(2):616-21; discussion 621. PubMed ID: 18082216
[TBL] [Abstract][Full Text] [Related]
37. GreenLight laser vaporization of the prostate: single-center experience and long-term results after 500 procedures.
Ruszat R; Seitz M; Wyler SF; Abe C; Rieken M; Reich O; Gasser TC; Bachmann A
Eur Urol; 2008 Oct; 54(4):893-901. PubMed ID: 18486311
[TBL] [Abstract][Full Text] [Related]
38. Holmium laser bladder neck incision versus holmium enucleation of the prostate as outpatient procedures for prostates less than 40 grams: a randomized trial.
Aho TF; Gilling PJ; Kennett KM; Westenberg AM; Fraundorfer MR; Frampton CM
J Urol; 2005 Jul; 174(1):210-4. PubMed ID: 15947629
[TBL] [Abstract][Full Text] [Related]
39. [Long-term results after prostate vaporisation : GreenLight™ laser vaporisation of the prostate and electrovaporisation].
Rieken M; Bachmann A; Shariat SF
Urologe A; 2016 Nov; 55(11):1440-1445. PubMed ID: 27680971
[TBL] [Abstract][Full Text] [Related]
40. Contact laser vaporization of the prostate in patients on chronic anticoagulant therapy.
Mueller EJ
Tech Urol; 1998 Sep; 4(3):156-9. PubMed ID: 9800899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
